Nicole Germino's Stock Ratings

Truist Securities Analyst

Nicole Germino is an analyst at Truist Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024

Overall Average Return

-3.13%

Smart Score

39.9%

Overall Average Return Percentile

31st

Number of Ratings

18
Buy NowGet Alert
07/01/2024INSMBuy Now
Insmed
$70.0525.62%$68 → $88MaintainsBuyGet Alert
06/28/2024YMABBuy Now
Y-mAbs Therapeutics
$11.2986.01% → $21Initiates → BuyGet Alert
05/29/2024INSMBuy Now
Insmed
$70.05-2.93%$48 → $68MaintainsBuyGet Alert
05/16/2024INSMBuy Now
Insmed
$70.05-31.48%$48 → $48MaintainsBuyGet Alert
04/23/2024INSMBuy Now
Insmed
$70.05-31.48% → $48Initiates → BuyGet Alert
03/20/2024FUSNBuy Now
Fusion Pharmaceuticals
——$11 → $21DowngradeBuy → HoldGet Alert
03/19/2024FUSNBuy Now
Fusion Pharmaceuticals
——$11 → $21DowngradeBuy → HoldGet Alert
11/07/2023SGMOBuy Now
Sangamo Therapeutics
$0.34——DowngradeBuy → HoldGet Alert
10/04/2023PNTBuy Now
POINT Biopharma Global
——$13 → $12.5DowngradeBuy → HoldGet Alert
08/15/2023SGMOBuy Now
Sangamo Therapeutics
$0.341961.25%$8 → $7MaintainsBuyGet Alert
05/10/2023SGMOBuy Now
Sangamo Therapeutics
$0.342255.71%$16 → $8MaintainsBuyGet Alert
11/15/2022PNTBuy Now
POINT Biopharma Global
——$22 → $14MaintainsBuyGet Alert
10/24/2022ASMBBuy Now
Assembly Biosciences
$12.50-84%$132 → $24DowngradeBuy → HoldGet Alert
09/16/2022FUSNBuy Now
Fusion Pharmaceuticals
—— → $10Initiates → BuyGet Alert
09/16/2022PNTBuy Now
POINT Biopharma Global
—— → $22Initiates → BuyGet Alert
04/05/2022SGMOBuy Now
Sangamo Therapeutics
$0.345494.82%$23 → $19MaintainsBuyGet Alert
04/01/2022ASMBBuy Now
Assembly Biosciences
$12.50-4%$180 → $144MaintainsBuyGet Alert
10/19/2020ASMBBuy Now
Assembly Biosciences
$12.50340% → $660Initiates → BuyGet Alert